Stereotactic ablative radiotherapy for locally advanced non-small cell lung cancer: A systematic review and meta-analysis

•268 patients in 7 trials submitted to SBRT were analyzed.•With SBRT the pooled 1-year local control (LC) rate was 80%.•BEDGy10 and neoadjuvant chemotherapy were associated with LC.•The 1-year and 2-year Overall Survival (OS) rates were 74% and 55% respectively.•A linear relationship between OS and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Radiotherapy and oncology 2024-12, Vol.201, p.110439, Article 110439
Hauptverfasser:	Viani, Gustavo A., Gouveia, Andre G., Louie, Alexander V., Arcidiacono, Fabio, Simone, Charles B., Tsakiridis, Theodoros, Carolina Hamamura, Ana, Anselmo, Paola, Moraes, Fabio Y.
Format:	Artikel
Sprache:	eng
Schlagworte:	Carcinoma, Non-Small-Cell Lung - mortality Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Non-Small-Cell Lung - radiotherapy Humans Local control Locally advanced Lung Neoplasms - mortality Lung Neoplasms - pathology Lung Neoplasms - radiotherapy Meta-analysis Non-small cell lung cancer (NSCLC) Overall survival Radiosurgery - adverse effects Radiosurgery - methods Stereotactic ablative radiotherapy (SABR) Stereotactic body radiotherapy (SBRT) Toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!